Zimmer Biomet Holdings's operating cash flow per share for the
three
months ended in Dec. 2023 was $2.82.
Zimmer Biomet Holdings's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $7.55.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Zimmer Biomet Holdings was 23.50% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 9.00% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -3.20% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 2.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Zimmer Biomet Holdings's Operating Cash Flow per Share or its related term are showing as below:
ZBH'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -11.9 Med: 8.9 Max: 57.9
Current: 9
During the past 13 years, Zimmer Biomet Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 57.90% per year. The lowest was -11.90% per year. And the median was 8.90% per year.
ZBH's 3-Year OCF Growth Rate is ranked better than 56.81% of 683
companies
in the Medical Devices & Instruments industry
Industry Median: 4.4
vs ZBH: 9.00
Zimmer Biomet Holdings Operating Cash Flow per Share Historical Data
The historical data trend for Zimmer Biomet Holdings's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Zimmer Biomet Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zimmer Biomet Holdings Price-to-Operating-Cash-Flow Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Zimmer Biomet Holdings's Price-to-Operating-Cash-Flow falls into.
Zimmer Biomet Holdings Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Zimmer Biomet Holdings's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.55
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zimmer Biomet Holdings Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Zimmer Biomet Holdings (Zimmer Biomet Holdings) Business Description
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZBH has been successfully added to your 